Table 1 Univariate analysis of SNORA68 and clinical pathology factors
Factors | Number (%) | SNORA68 expression | χ2 | P-value | |
|---|---|---|---|---|---|
Low (%) | High (%) | ||||
Age(years) | Â | Â | Â | 1.450 | 0.229 |
 < 60 | 54 (67.5) | 22 (40.74) | 32 (59.26) |  |  |
 > 61 | 26 (32.50) | 7 (26.92) | 19 (73.08) |  |  |
Family history | |||||
No | 58 (72.50) | 21 (36.20) | 37 (63.80) | 0.000 | 0.990 |
Yes | 22 (27.50) | 8 (36.36) | 14 (63.64) | Â | Â |
Menstrual history | |||||
Pre-menopause | 35 (43.75) | 14 (40.00) | 21 (60.00) | 0.980 | 0.613 |
Perimenopause | 9 (11.25) | 4 (44.44) | 5 (55.56) | Â | Â |
Menopause | 36 (45.00) | 11 (30.56) | 25 (69.44) | Â | Â |
Tumor size(cm) | Â | Â | Â | 3.903 | 0.048* |
 < 2 | 25 (31.25) | 13 (52.00) | 12 (48.00) |  |  |
 ≥ 2 | 55 (68.75) | 16 (29.10) | 39 (70.90) |  |  |
Number of lymph node metastasis | Â | Â | Â | 1.335 | 0.513 |
0 | 32 (40.00) | 12 (37.50) | 20 (62.50) | Â | Â |
1–3 | 38 (47.50) | 15 (39.47) | 23 (60.53) |  |  |
 > 3 | 10 (12.50) | 2 (20.00) | 8 (80.00) |  |  |
Histological grade | Â | Â | Â | 2.173 | 0.338 |
1 | 25 (31.25) | 12 (48.00) | 13 (52.00) | Â | Â |
2 | 42 (55.00) | 13 (30.95) | 29 (69.05) | Â | Â |
3 | 13 (16.25) | 4 (30.76) | 9 (69.23) | Â | Â |
Ki67 | Â | Â | Â | 4.363 | 0.037* |
 < 30 | 32 (40.00) | 16 (50.00) | 16 (50.00) |  |  |
 > 31 | 48 (60.00) | 13 (27.08) | 35 (72.92) |  |  |
TNM staging | Â | Â | Â | 8.452 | 0.015* |
I | 17 (21.25) | 11 (64.71) | 6 (35.29) | Â | Â |
II | 41 (51.25) | 10 (24.39) | 31 (75.61) | Â | Â |
III | 22 (27.50) | 8 (36.36) | 14 (63.64) | Â | Â |